Sun PharmaceuticalSUNPHARMA

SUNPHARMASun Pharmaceutical₹1,820.4▲ 1.46% today

Nifty 50

Sun Pharmaceutical Industries is India's largest pharma company with a growing specialty franchise.

Key products	Specialty (dermatology, ophthalmology — Ilumya, Cequa) and generics; APIs.
Geography	US, India and emerging markets.
Competitors	Cipla, Dr Reddy's, Lupin.

AI-generated overview — verify before relying on it.

Net institutional flow

+₹0 Cr

Institutional buyers

2 in / 2 out

High-impact filings

0 · tilt Neutral

Next corporate action

Interim Dividend - Rs 11 Per Share

ex 2026-02-05

Competitive landscape — the read

vs mapped peers · 1Y

1M 3M 6M 1Y 2Y All

Institutional money is backing ALKEM hardest (+₹1,013.7 Cr net). SUNPHARMA ranks #2 of 9 on flow (net buying +₹0 Cr). Filing momentum favours ZYDUSLIFE (+1). News & social buzz is most positive on DRREDDY.

#	Company	Inst. flow ₹Cr	Deals	Hi-impact	Filing mom.	Buzz	News
1	ALKEM	+₹1,013.7 Cr	13	—	—	-2	6
2	SUNPHARMAThis	+₹0 Cr	6	—	—	+15	45
3	CIPLA	+₹0 Cr	4	—	—	+19	44
4	DRREDDY	+₹0 Cr	4	—	—	+20	46
5	TORNTPHARM	—	—	—	—	—	—
6	LUPIN	+₹0 Cr	4	—	—	—	—
7	ZYDUSLIFE	—	—	1	+1	—	—
8	AUROPHARMA	+₹0 Cr	2	—	—	—	—
9	MANKIND	+₹0 Cr	4	—	—	—	—

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — SUNPHARMA day by day

1M 3M 6M 1Y 2Y All

2026-06-16FilingNewspaper Publication containing information about transfer of equity shares and unclaimed dividends to the InCompliance
2026-06-16NewsCipla expands respiratory, specialty manufacturing across India, China, USTopic · Specialty
2026-06-16NewsCipla expands respiratory, specialty manufacturing across India, China, USTopic · Specialty
2026-06-15NewsSun Pharmaceutical Industries Ltd Stock (INE044A01036): India pharma heavyweight in focus after receAD HOC NEWS
2026-06-15NewsSUN PHARMACEUTICAL IND L Share Price TodayUpstox
2026-06-14FilingIntimation under Regulation 30 of SEBI (LODR) Regulations 2015General
2026-06-14NewsSun Pharma intimation of arrest of Independent Director Gautam Doshiscanx.trade
2026-06-13NewsThird Wave Coffee Brings Specialty Coffee Culture to Kolkata with Triple Store LaunchTopic · Specialty
2026-06-12NewsSun Pharmaceutical Industries climbs Friday, underperforms marketMarketWatch
2026-06-12NewsIndia’s pharma role is expanding beyond genericsTopic · generics
2026-06-12NewsSun Pharmaceutical fixes record date for ₹5 final dividendscanx.trade
2026-06-12NewsSun Pharmaceutical Industries fixes record date for final dividendBusiness Standard
2026-06-12NewsSun Pharmaceutical Industries fixes record date for final dividendBusiness Standard
2026-06-11FilingSun Pharmaceutical Industries Limited has informed the Exchange that Record date for the purpose of Final DiviDividend
2026-06-11FilingIntimation of 34th Annual General Meeting and Record Date for Final Dividend and connected mattersDividend
2026-06-11NewsBuy Sun Pharmaceutical Industries Ltd for the Target Rs.2,300 by Choice Institutional EquitiesTopic · India
2026-06-11NewsELANTAS Beck India strengthens specialty chemicals capabilities to support India's expanding data center sectoTopic · Specialty
2026-06-10NewsSun Pharmaceutical Industries rises Wednesday, outperforms competitorsMarketWatch
2026-06-09NewsSBI in $1 billion funding for Sun Pharma’s US dealTopic · India
2026-06-09NewsIndia’s Top Bank in $1 Billion Funding for Sun Pharma’s US DealTopic · India
2026-06-08NewsSun Pharmaceutical Industries Ltd Corporate ActionsTopic · India
2026-06-08NewsSun Pharmaceutical Industries Ltd Stock Price: Sun Pharma.Inds. Share Price TodayIndia Infoline
2026-06-03NewsDoctors’ bodies demand surrender of 151 vacant in-service super specialty seats to All India QuotaTopic · Specialty
2026-05-31NewsIndia's coffee growers chase specialty boomTopic · Specialty
2026-02-05ActionInterim Dividend - Rs 11 Per ShareDividend
2025-11-18BlockBUY · ₹255.1 CrGQG PARTNERS EMERGING MARKETS EQUITY CIT
2025-11-18BlockSELL · ₹255.1 CrRELIANCE TRUST INSTITUTIONAL RETIREMENT TRUST SERIES TWELVE
2025-10-09BlockSELL · ₹24.2 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
2025-10-09BlockBUY · ₹24.2 CrGOLDMAN SACHS BANK EUROPE SE - ODI
2025-07-14BlockSELL · ₹51.7 CrTHE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828
2025-07-14BlockBUY · ₹51.7 CrTHE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849
2025-07-07ActionDividend - Rs 5.50 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

1
ComplianceNeutral
Newspaper Publication containing information about transfer of equity shares and unclaimed dividends to the Investor Education and Protection Fund (IEPF) Account
Source PDF →
2
GeneralNeutral
Intimation under Regulation 30 of SEBI (LODR) Regulations 2015
Source PDF →
3
DividendNeutral
Record date announcement for final dividend.
Source PDF →
2
DividendNeutral
Routine dividend announcement with no significant market impact.
Source PDF →

Bulk & block deals

1M 3M 6M 1Y 2Y All

6 deals · 2025-07-14 → 2025-11-18

Date	Counterparty	Type	Side	Value
2025-11-18	GQG PARTNERS EMERGING MARKETS EQUITY CIT	Institution	BUY	₹255.1 Cr
2025-11-18	RELIANCE TRUST INSTITUTIONAL RETIREMENT TRUST SERIES TWELVE	Institution	SELL	₹255.1 Cr
2025-10-09	GOLDMAN SACHS (SINGAPORE) PTE - ODI	HNI / other	SELL	₹24.2 Cr
2025-10-09	GOLDMAN SACHS BANK EUROPE SE - ODI	HNI / other	BUY	₹24.2 Cr
2025-07-14	THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828	Institution	SELL	₹51.7 Cr
2025-07-14	THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849	Institution	BUY	₹51.7 Cr